Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $10.10 million. The enterprise value is -$12.92 million.

Market Cap	10.10M
Enterprise Value	-12.92M

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

SNSE has 1.26 million shares outstanding. The number of shares has increased by 0.52% in one year.

Current Share Class	1.26M
Shares Outstanding	1.26M
Shares Change (YoY)	+0.52%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	4.55%
Float	828,299

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.09.

Current Ratio	5.81
Quick Ratio	5.64
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-520.74

Financial Efficiency

Return on equity (ROE) is -70.18% and return on invested capital (ROIC) is -39.78%.

Return on Equity (ROE)	-70.18%
Return on Assets (ROA)	-37.04%
Return on Invested Capital (ROIC)	-39.78%
Return on Capital Employed (ROCE)	-103.46%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.69% in the last 52 weeks. The beta is 0.31, so SNSE's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-24.69%
50-Day Moving Average	9.92
200-Day Moving Average	8.48
Relative Strength Index (RSI)	38.81
Average Volume (20 Days)	36,691

Short Selling Information

The latest short interest is 28,027, so 2.22% of the outstanding shares have been sold short.

Short Interest	28,027
Short Previous Month	15,041
Short % of Shares Out	2.22%
Short % of Float	3.38%
Short Ratio (days to cover)	0.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.95M
Pretax Income	-24.14M
Net Income	-24.14M
EBITDA	-23.52M
EBIT	-23.95M
Earnings Per Share (EPS)	-$19.16

Balance Sheet

The company has $25.04 million in cash and $2.02 million in debt, giving a net cash position of $23.02 million or $18.25 per share.

Cash & Cash Equivalents	25.04M
Total Debt	2.02M
Net Cash	23.02M
Net Cash Per Share	$18.25
Equity (Book Value)	23.01M
Book Value Per Share	18.24
Working Capital	21.35M

Cash Flow

In the last 12 months, operating cash flow was -$22.38 million and capital expenditures -$16,000, giving a free cash flow of -$22.40 million.

Operating Cash Flow	-22.38M
Capital Expenditures	-16,000
Free Cash Flow	-22.40M
FCF Per Share	-$17.76

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.52%
Shareholder Yield	-0.52%
Earnings Yield	-239.07%
FCF Yield	-221.83%

Analyst Forecast

The average price target for SNSE is $72.50, which is 805.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$72.50
Price Target Difference	805.68%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-12.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1